Institute for Myeloma & Bone Cancer Research
In research, Institute for Myeloma & Bone Cancer Research stands highest in Medicine (#17,012 of 17,978 worldwide) and Health Sciences (#19,766 of 20,462 worldwide), over all time.
- World rank, all time
- #36,227 of 42,892
- Rank in United States
- #7,652 of 8,685
- Research works
- 181 ▼ 25% vs 2013–17
- Citations
- 2.8k 15.7 per fractional work
- Top-10% rate
- 5.4% record average 16.5%
- Open access
- 15% world 28%
What is Institute for Myeloma & Bone Cancer Research known for in research?
The fields where it stands highest, over all time, ranked among every institution above the floor in each field.
| Field | World rank | Where that sits | Top-10% rate | Works |
|---|---|---|---|---|
| MedicineField | #17,012 of 17,978 | 10.0% | 121 | |
| Health SciencesDomain | #19,766 of 20,462 | 10.0% | 121 |
Each strip is that field’s whole ranked pool, with the notch where Institute for Myeloma & Bone Cancer Research sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Pharmacology, Toxicology and Pharmaceutics, 6.5×. Every wedge is a field page.
- Pharmacology, Toxicology and Pharmaceutics 6.5×
- Immunology and Microbiology 4.1×
- Medicine 3.9×
- Biochemistry, Genetics and Molecular Biology 2.2×
- Decision Sciences 1.1×
- Arts and Humanities 0.7×
- Economics, Econometrics and Finance 0.5×
- Mathematics 0.1×
- Agricultural and Biological Sciences 0.1×
- Social Sciences 0.1×
Who are the top researchers at Institute for Myeloma & Bone Cancer Research?
Ranked on the composite score, James R. Berenson, Haiming Chen and Mingjie Li lead among researchers whose main affiliation is Institute for Myeloma & Bone Cancer Research.
- 1 James R. Berenson United States · #237,694 worldwide 164 citations · 60 works
- 2 Haiming Chen United States · #492,145 worldwide 66 citations · 28 works
- 3 Mingjie Li United States · #517,266 worldwide 55 citations · 26 works
- 4 Eric Sanchez United States · #659,641 worldwide 34 citations · 17 works
Which keywords describe research at Institute for Myeloma & Bone Cancer Research?
By fractional works in all years, weighted toward what it does more of than the world: Proteasome Inhibitors, Staging System, Minimal Residual Disease, Diagnosis Criteria, International Myeloma Working Group, Cancer Therapy, Transcriptional Regulation and Angiogenesis.
- Genomic Aberrations
- Ubiquitin
- Proteasome
- Mucins
- Immune System
- Therapeutic Targets
- Taxanes
- N-terminal Acetylation
- Immunosuppression
- Fc Receptors
- Bisphosphonates
- Clinical Practice Guidelines
- Tumor Microenvironment
- PET Imaging
- BET Bromodomains
- Inflammation
- Transcriptional Regulation
- Cancer Therapy
- Diagnosis Criteria
- Staging System
- Proteasome Inhibitors
- Minimal Residual Disease
- International Myeloma Working Group
- Cancer
- Angiogenesis
- Cancer Treatment
- Glycosylation
- PROTACs
- Breast Cancer
- Prognostic Factors
- Osteonecrosis of the Jaw
- Therapeutic Antibodies
- Fibroblast Activation Protein
- Chemotherapy-Induced Peripheral Neuropathy
- Rituximab
- Immunity
- Glycans
- Cell Signaling
- Targeted Therapy
- Chronic Lymphocytic Leukemia
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Proteasome Inhibitors50▲ 393×2 topics
- Staging System45▲ 398×2 topics
- Minimal Residual Disease45▲ 376×2 topics
- Diagnosis Criteria45▲ 825×1 topic
- International Myeloma Working Group45▲ 825×1 topic
- Cancer Therapy17▲ 15×11 topics
- Cancer14▲ 5.7×22 topics
- Transcriptional Regulation14▲ 30×7 topics
- Angiogenesis14▲ 18×8 topics
- Inflammation13▲ 3.0×19 topics
- Cancer Treatment12▲ 27×4 topics
- BET Bromodomains12▲ 337×1 topic
- Glycosylation12▲ 31×2 topics
- PET Imaging12▲ 32×3 topics
- PROTACs12▲ 337×1 topic
- Tumor Microenvironment10▲ 15×4 topics
- Breast Cancer8▲ 17×3 topics
- Clinical Practice Guidelines8▲ 8.2×5 topics
- Prognostic Factors8▲ 10×7 topics
- Bisphosphonates8▲ 109×1 topic
- Osteonecrosis of the Jaw8▲ 109×1 topic
- Fc Receptors8▲ 42×1 topic
- Therapeutic Antibodies8▲ 32×1 topic
- Immunosuppression7▲ 33×2 topics
- Fibroblast Activation Protein7▲ 71×1 topic
- N-terminal Acetylation7▲ 71×1 topic
- Chemotherapy-Induced Peripheral Neuropathy6▲ 69×1 topic
- Taxanes6▲ 69×1 topic
- Rituximab6▲ 20×3 topics
- Therapeutic Targets6▲ 14×3 topics
- Immunity5▲ 8.4×6 topics
- Immune System5▲ 8.2×2 topics
- Glycans5▲ 33×1 topic
- Mucins5▲ 33×1 topic
- Cell Signaling5▲ 7.7×5 topics
- Proteasome5▲ 65×1 topic
- Targeted Therapy5▲ 12×4 topics
- Ubiquitin5▲ 65×1 topic
- Chronic Lymphocytic Leukemia4▲ 51×1 topic
- Genomic Aberrations4▲ 51×1 topic
Which research topics does Institute for Myeloma & Bone Cancer Research publish most on?
By volume in 2022–2025: Multiple Myeloma Research and Treatments, Myeloproliferative Neoplasms: Diagnosis and Treatment, Protein Degradation and Inhibitors and Monoclonal and Polyclonal Antibodies Research.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Multiple Myeloma Research and Treatments Hematology 4 works
- 2 Myeloproliferative Neoplasms: Diagnosis and Treatment Genetics 1 works
- 3 Protein Degradation and Inhibitors Molecular Biology 1 works
- 4 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 1 works
- 5 Chronic Lymphocytic Leukemia Research Genetics 1 works
- 6 Peptidase Inhibition and Analysis Oncology 0 works
- 7 Chemokine receptors and signaling Oncology 0 works
- 8 Immunotherapy and Immune Responses Immunology 0 works
- 9 CAR-T cell therapy research Oncology 0 works
- 10 Lymphoma Diagnosis and Treatment Pathology and Forensic Medicine 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Institute for Myeloma & Bone Cancer Research's research output changed?
Output in 2018–2022 was 25% lower than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in West Hollywood
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.